Epidemiología de las lesiones precancerosas y verrugas genitales asociadas a infección por virus del papiloma humano en España

Walboomers, 1999, Human papillomavirus is a necessary cause of invasive cervical cancer worldwide, J Pathol., 189, 12, 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F Clifford, 2003, Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis, Br J Cancer., 89, 101, 10.1038/sj.bjc.6601024 Schiffman, 2005, The carcinogenicity of human papillomavirus types reflects viral evolution, Virology., 337, 76, 10.1016/j.virol.2005.04.002 Clifford, 2005, Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer, Cancer Epidemiol Biomarkers Prev., 14, 1157, 10.1158/1055-9965.EPI-04-0812 Muñoz, 2003, Epidemiologic classification of human papillomavirus types associated with cervical cancer, N Engl J Med., 348, 518, 10.1056/NEJMoa021641 Clifford, 2003, Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis, Br J Cancer., 88, 63, 10.1038/sj.bjc.6600688 Gissmann, 1983, Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers, Proc Natl Acad Sci USA., 80, 560, 10.1073/pnas.80.2.560 Ferlay, 2004 Wilson, 2001, Emerging therapies for human papillomavirus infection, Expert Opin Emerg Drugs., 6, 199, 10.1517/14728214.6.2.199 Langley, 1999, The cost effectiveness of patient-applied versus provider-administered intervention strategies for the treatment of external genital warts, Am J Manag Care., 5, 69 The UK Collaborative Group for HIV and STI Surveillance. A Complex Picture. HIV and other sexually transmitted infections in the United Kingdom: 2006. London: Health Protection Agency, Centre for Infections; 2006. Documento de consenso de las sociedades científicas. Vacunas profilácticas frente a VPH. Enero 2007. Disponible en: http://www.vacunasaep.org/pdf/2007/consenso_sociedades_vacuna%20_vph.pdf Bray, 2005, Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening, Cancer Epidemiol Biomarkers Prev., 14, 677, 10.1158/1055-9965.EPI-04-0569 Vizcaíno, 2000, Inyernational trends in incidence of cervical cancer: Squamous-cell carcinoma, Int J Cancer., 86, 429, 10.1002/(SICI)1097-0215(20000501)86:3<429::AID-IJC20>3.0.CO;2-D Suris, 1998, Survival in cervical cancer, Eur J Gynaecol Oncol., 19, 11 Llorca, 2006, Cervical cancer mortality is increasing in Spanish women younger than 50, Cancer Lett., 240, 36, 10.1016/j.canlet.2005.08.021 Puig-Tintoré, 2008, Coverage and factors associated with cervical cancer screening: results from the AFRODITA study: a population-based survey in Spain, J Low Genit Tract Dis., 12, 82, 10.1097/LGT.0b013e3181599c16 Cantor, 2005, Natural history of cervical intraepithelial neoplasia: a meta-analysis, Acta Cytol., 49, 405, 10.1159/000326174 Puig-Tintoré, 2006, Prevención del cáncer de cuello uterino, ante la vacunación frente al virus de papiloma humano, Prog Obstet Ginecol., 49, 5 De Sanjosé, 2008, Age at sexual initiation and number of sexual partners in the female Spanish population. Results from the AFRODITA survey, Eur J Obstet Gynecol Reprod Biol., 140, 234, 10.1016/j.ejogrb.2008.04.005 Health Protection Agency Centre for Infections. Diagnoses and rates of selected STIs seen at GUM clinics: 2001-2005. National & Regional Level Summary tables. 22-11-2006.21-5-2007. Ref Type: Internet Communication. Hillemanns, 2008, Estimation of the incidente of genital warts and the costo f illness in Germany: a cross-sectional study, BMC Infect Dis., 8, 76, 10.1186/1471-2334-8-76 Monsonego, 2007, Anogenital warts incidence, medical management and costs in women consulting gynaecologists in France, Gynecol Obstet Fertil., 35, 107 Bergeron, 2006, Cervical cancer screening and associated treatment costs in France, Gynecol Obstet Fertil., 34, 103642 Bergeron C, Cartier I, Guldner L, Lassalle M, Savignoni A, Asselain B. Precancerous lesions and cervical cancer diagnosed by cervical Pap semear, Ile-de-France, Crisap survey [Lèsions précancéreuses et CCs du col de l’utérus diagnostiqués par le frottis cervical], 2002. BEH. 2005; 2:5-6. Disponible en: http://www.invs.sante.fr/beh/2005/02/beh_02_2005.pdf Giorgi-Rossi P, Largeron N, Cohet C, Palazzo F, Mennini FS, Furnari G, Federici A, Valle S. Impact and cost of cervical cancer prevention in Italy. Abstract. 4th Annual Meeting of Health Technology Assessment Internacional (HTAi), Barcelona, Spain, 2007. Brown, 2006, Costs of detection and treatment of cervical cancer, cervical dysplasia and genital warts in the UK, Curr Med Res Opin., 22, 663, 10.1185/030079906X99972 Petry, 2008, Cost of screening and treatment of cervical dyskaryosis in Germany, Eur J Gynaecol Oncol., 29, 345 Petry, 2003, Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients, Br J Cancer., 88, 15707, 10.1038/sj.bjc.6600918 Volante, 2006, National survey of the quality of 2nd level in screening for cervical câncer, Epidemiol Prev., 30, 51